Open AccessProspects of PARP Inhibitors in Treatment of BRCA-Mutated Pancreatic Cancer: a Literature Review
Author(s) -
К. V. Menshikov,
А. V. Sultanbaev,
Ш. И. Мусин,
А. А. Измайлов,
I. A. Menshikovа,
Н. И. Султанбаева,
E. V. Popova,
L. A. Khammatova
Publication year - 2022
Publication title -
kreativnaâ hirurgiâ i onkologiâ
Language(s) - English
Resource type - Journals
eISSN - 2307-0501
pISSN - 2076-3093
DOI - 10.24060/2076-3093-2022-12-1-48-55
Subject(s) - pancreatic cancer , medicine , parp inhibitor , gemcitabine , targeted therapy , oncology , palb2 , cancer research , ovarian cancer , adenocarcinoma , cancer , brca mutation , germline mutation , bioinformatics , mutation , biology , genetics , gene , poly adp ribose polymerase , polymerase